Related Articles
Gomisin A enhances the antitumor effect of paclitaxel by suppressing oxidative stress in ovarian cancer
Chemokine CCL20 promotes the paclitaxel resistance of CD44<sup>+</sup>CD117<sup>+</sup> cells via the Notch1 signaling pathway in ovarian cancer
A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties Corrigendum in /10.3892/ol.2022.13526
ERp57‑small interfering RNA silencing can enhance the sensitivity of drug‑resistant human ovarian cancer cells to paclitaxel
Human epithelial ovarian cancer cells expressing CD105, CD44 and CD106 surface markers exhibit increased invasive capacity and drug resistance